1 – 10 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting(
- Contribution to conference › Poster
-
Mark
Vitamin D derivatives inhibit mesenchymal transition of mesothelial cells and mitigate peritoneal dissemination of ovarian cancer
2025) In Medical Molecular Morphology(
- Contribution to journal › Article
-
Mark
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation : Final overall survival results from the OPINION trial
(
- Contribution to journal › Article
-
Mark
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
- 2024
-
Mark
Cancer Evolution under Chemotherapy Treatment
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population
(
- Contribution to journal › Article
-
Mark
Tumor-associated fibrosis : a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
(
- Contribution to journal › Scientific review
-
Mark
Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Safe to save blood in ovarian cancer surgery : time to change transfusion habits
(
- Contribution to journal › Article
-
Mark
An explainable machine learning model to solid adnexal masses diagnosis based on clinical data and qualitative ultrasound indicators
(
- Contribution to journal › Article